HER2-positive breast cancer at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
10 organizations at SABCS 2026 present work in her2-positive breast cancer: 9 drug developers and 1 diagnostics, device or service company. 10 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–10 of 10 organizations
| Organization | SABCS 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker whose breast cancer medicines include HER2- and TROP2-directed antibody-drug conjugates and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 624 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
BioNTech Mainz, Germany | |
Biotech company developing mRNA and other cancer immunotherapies and antibody-drug conjugates, including a HER2-directed ADC in breast cancer trials. | Booth Exhibiting at Booth 251 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Daiichi Sankyo Tokyo, Japan | |
Japanese drugmaker whose oncology portfolio centers on antibody-drug conjugates, including HER2- and TROP2-directed treatments used in breast cancer. | Booth Exhibiting at Booth 343 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Genentech South San Francisco, CA | |
Roche Group biotechnology company whose breast cancer medicines include HER2-targeted antibodies and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 125 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Greenwich LifeSciences Stafford, TX | |
Clinical-stage biotech testing GP2, a HER2 peptide immunotherapy, in the Phase III Flamingo-01 trial to prevent breast cancer from returning. | Booth Exhibiting at Booth 809 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Jazz Pharmaceuticals Dublin, Ireland | |
Global biopharma company with medicines for serious diseases, including zanidatamab, a HER2-targeted bispecific antibody studied in breast cancer. | Booth Exhibiting at Booth 1642 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Organon Jersey City, NJ | |
Women's health drugmaker whose portfolio includes biosimilars, among them a trastuzumab biosimilar for HER2-positive breast cancer. | Booth Exhibiting at Booth 1209 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Pfizer New York, NY | |
Global drugmaker whose breast cancer medicines include treatments for hormone receptor-positive and HER2-positive disease. | Booth Exhibiting at Booth 1124 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Puma Biotechnology Los Angeles, CA | |
Markets NERLYNX (neratinib) for HER2-positive breast cancer and is testing alisertib with hormone therapy in HR+/HER2- metastatic breast cancer. | Booth Exhibiting at Booth 209 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Reveal Genomics Barcelona, Spain | |
Barcelona company behind HER2DX, a genomic test that estimates recurrence risk and treatment response in early HER2-positive breast cancer. | Booth Exhibiting at Booth 1252 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers in her2-positive breast cancer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse SABCS 2026 by
Organization type
Focus
- Patient and family support 26
- Genomic and tumor testing 22
- Hormone receptor-positive breast cancer 17
- Clinical trials and research 16
- HER2-positive breast cancer 10
- Liquid biopsy and MRD 10
- AI and data 9
- Screening and early detection 9
- Side effects and supportive care 8
- Breast surgery and biopsy 8
- Metastatic breast cancer 5
- Triple-negative breast cancer 4
- Hereditary risk and genetic testing 4
Exhibit hall
Everyone
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction